Screener / Anemia & Cancer Treatments / FibroGen Inc

FGEN · NASDAQ

FibroGen Inc

Compliant

Under AAOIFI Standard 21, FibroGen Inc is compliant. Its core business is permissible and its interest-bearing debt is below 30% of market cap.

TickerFGEN
ExchangeNASDAQ
SectorAnemia & Cancer Treatments

Full ratios for FibroGen Inc (impure revenue, debt and interest-bearing deposits under all four standards) are being added. Until then this page shows the screening verdict only. See the methodology for how each test works. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding FibroGen Inc or any other security.